YIH
RBOT

Y-Intercept (HK)’s Vicarious Surgical RBOT Stock Holding History

Y-Intercept (HK)’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,534
Closed -$61.8K – 1719
2024
Q2 		$61.8K Buy
+10,534
New +$94.3K ﹤0.01% 1288
2022
Q2 		– Sell
-471
Closed -$71K – 1134
2022
Q1 		$71K Buy
+471
New +$87.6K 0.02% 686

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return

Y-Intercept (HK)'s RBOT Position: Q3 2024 in Review

Y-Intercept (HK) sold out of Vicarious Surgical (RBOT) in Q3 2024, closing a stake of 10,534 shares — an estimated $61.8K sold.

Y-Intercept (HK) first reported a position in RBOT in Q1 2022 and held it in 2 quarters. The position peaked at $71K in Q1 2022. 34 funds tracked by Wall St. Rank hold RBOT as of Q3 2024.

  • Y-Intercept (HK) reported no remaining Vicarious Surgical position as of Q3 2024 after selling out during the quarter.
  • Y-Intercept (HK) sold 10,534 Vicarious Surgical shares in Q3 2024, an estimated $61.8K.
  • Y-Intercept (HK) first reported a position in Vicarious Surgical in Q1 2022 and held it in 2 quarters.
  • Y-Intercept (HK)'s Vicarious Surgical position peaked at $71K in Q1 2022.
  • 34 funds tracked by Wall St. Rank held Vicarious Surgical as of Q3 2024.

Based on Y-Intercept (HK)'s 13F filing for Q3 2024, filed 15 Nov 2024.